Antiemetic guidelines: Creating a more practical treatment approach

Supportive Care in Cancer

Volumn 10, Issue 7, 2002, Pages 519-522

  Koeller, Jim M ^a   Aapro, Matti S ^b   Gralla, Richard J ^c   Grunberg, Steven M ^d   Hesketh, Paul J ^e   Kris, Mark G ^f   Clark Snow, Rebecca A ^g  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b CLINIQUE DE GENOLIER   (Switzerland)

^c Milstein Hospital   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e ST ELIZABETH'S MEDICAL CENTER   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g UNIVERSITY OF KANSAS CANCER CENTER   (United States)

Author keywords

Antiemetic treatment guidelines; Appropriate use; Chemotherapy induced nausea and vomiting

Indexed keywords

ALTRETAMINE; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; AZASETRON; CARBOPLATIN; CARMUSTINE; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DEXAMETHASONE; DOLASETRON MESILATE; DOXORUBICIN; EPIRUBICIN; GRANISETRON; IDARUBICIN; IFOSFAMIDE; IRINOTECAN; LOMUSTINE; MELPHALAN; METOCLOPRAMIDE; MITOXANTRONE; ONDANSETRON; PENTOSTATIN; PROCARBAZINE; SEROTONIN 3 ANTAGONIST; STREPTOZOCIN; TROPISETRON; UNINDEXED DRUG;

ARTICLE; CHEMOTHERAPY INDUCED EMESIS; CLINICAL PRACTICE; CLINICAL TRIAL; DOCUMENTATION; DOSE RESPONSE; DRUG CHOICE; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HUMAN; META ANALYSIS; NAUSEA; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTIEMETICS; ANTINEOPLASTIC AGENTS; HUMANS; NAUSEA; PRACTICE GUIDELINES; RISK ASSESSMENT; VOMITING;

EID: 0036933329     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-001-0335-y     Document Type: Article

References (7)

1. Herrstedt J, Aapro MS, Smyth JF, Del Favero A (1997) Corticosteroids, dopamine antagonists, and other drugs. In: Gralla RJ, Tonato M, Roila F (eds) Perugia Consensus Conference on Antiemetic Therapy. Springer, Berlin Heidelberg New York, pp 1-20
2. Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, et al (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J Clin Oncol 17:2971-2994
3. ASHP Commission on Therapeutics (1999) ASHP Therapeutic guidelines on the pharmacologic management of nausea and vomiting. Am J Health Syst Pharm 56:729-764
4. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC) (1998) Ann Oncol 9:811-819
5. Antiemesis Practice Guidelines Panel (1997) NCCN Antiemesis practice guidelines. (NCCN proceedings) Oncology 11:57-89
6. Roila F, De Angelis V, Patoia L, Pignata S, Sorio R, Labianca R, Iacono C, Lelli G, Tonato M (2000) Antiemetic prescriptions in 77 Italian Oncological Centers after MASCC Consensus Conference. Support Care Cancer 8:241
7. Canadian Medical Association (1979) The Canadian task force on the periodic health examination (1979) CMAJ 121:1193-1254